Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free CDLX Stock Alerts

Cardlytics (CDLX) Financials

Cardlytics logo
$4.32 +0.16 (+3.85%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$4.32 0.00 (0.00%)
As of 07/10/2026 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Cardlytics

Annual Income Statements for Cardlytics

This table shows Cardlytics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -77 -25 -53 -17 -55 -129 -465 -135 -189 -103
Consolidated Net Income / (Loss)		 -76 -20 -53 -17 -55 -129 -465 -135 -189 -103
Net Income / (Loss) Continuing Operations		 -76 -20 -53 -17 -55 -129 -465 -135 -189 -103
Total Pre-Tax Income 		-76 -20 -53 -17 -55 -136 -467 -135 -189 -103
Total Operating Income		 -56 -17 -41 -17 -54 -123 -458 -136 -195 -102
Total Gross Profit		 113 130 151 210 187 267 299 309 278 233
Total Revenue		 113 130 151 210 187 267 299 309 278 233
Operating Revenue		 113 130 151 210 187 267 299 309 278 233
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 169 147 192 228 241 390 756 445 474 335
Selling, General & Admin Expense		 21 20 34 37 47 66 81 59 56 47
Marketing Expense		 31 32 42 44 45 66 75 57 53 39
Research & Development Expense		 14 12 16 12 18 38 54 51 50 40
Depreciation Expense		 4.22 3.03 3.28 4.54 7.83 30 38 26 26 25
Other Operating Expenses / (Income)		 98 80 96 131 124 190 55 180 158 124
Impairment Charge		 - - - - 0.00 0.00 453 71 132 59
Total Other Income / (Expense), net		 -19 -2.54 -12 0.18 -1.50 -14 -8.93 0.97 6.20 -1.67
Interest Expense		 6.17 8.24 3.26 0.55 3.05 13 0.00 0.00 -13 0.00
Interest & Investment Income		 - - - - - - -2.56 -2.34 -5.55 -7.92
Other Income / (Expense), net		 -13 5.70 -8.86 0.73 1.55 -1.27 -6.38 3.30 -1.27 6.25
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 -7.86 -1.45 0.00 0.00 0.00
Basic Earnings per Share		 ($32.48) ($7.86) ($2.79) ($0.72) ($2.04) ($3.99) ($13.92) ($3.69) ($3.91) ($1.95)
Weighted Average Basic Shares Outstanding		 2.36M 3.23M 19.06M 23.75M 27.21M 32.20M 33.42M 36.49M 48.36M 53.11M
Diluted Earnings per Share		 ($32.48) ($7.86) ($2.79) ($0.72) - - ($13.92) ($3.69) ($3.91) ($1.95)
Weighted Average Diluted Shares Outstanding		 2.36M 3.23M 19.06M 23.75M 27.21M 32.20M 33.42M 36.49M 48.36M 53.11M
Weighted Average Basic & Diluted Shares Outstanding		 2.36M 3.23M 19.06M 23.75M 27.21M 32.20M 33.61M 44.11M 52.09M 55.05M

Quarterly Income Statements for Cardlytics

This table shows Cardlytics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -24 -101 -24 -4.26 -145 -16 -13 -9.28 -73 -8.25 -4.48
Consolidated Net Income / (Loss)		 -24 -101 -24 -4.26 -145 -16 -13 -9.28 -73 -8.25 -4.48
Net Income / (Loss) Continuing Operations		 -24 -101 -24 -4.26 -145 -16 -10 -9.28 -73 -8.25 -14
Total Pre-Tax Income 		-24 -101 -24 -4.26 -145 -16 -10 -9.28 -73 -8.25 -14
Total Operating Income		 -21 -103 -23 -16 -149 -8.32 -11 -13 -69 -6.09 -8.27
Total Gross Profit		 79 89 68 70 67 74 56 63 52 56 34
Total Revenue		 79 89 68 70 67 74 56 63 52 56 34
Operating Revenue		 79 89 68 70 67 74 56 63 52 56 34
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 100 192 90 85 216 82 68 76 121 62 43
Selling, General & Admin Expense		 16 14 14 16 12 14 13 13 11 9.73 8.28
Marketing Expense		 14 14 14 14 13 11 10 11 7.87 7.52 6.76
Research & Development Expense		 12 13 13 13 13 9.90 10 11 8.80 7.97 6.43
Depreciation Expense		 5.99 6.70 6.25 6.53 6.97 5.94 4.35 6.28 6.47 6.21 3.94
Other Operating Expenses / (Income)		 51 66 43 35 39 42 35 34 28 31 17
Other Special Charges / (Income)		 - - - 0.00 0.00 - -5.35 0.20 0.32 - 0.00
Total Other Income / (Expense), net		 -3.31 2.09 -1.45 12 3.36 -7.28 0.80 3.51 -3.82 -2.16 -5.52
Interest & Investment Income		 - - - -1.56 -1.48 - -1.83 -1.94 -2.01 - -3.82
Other Income / (Expense), net		 -2.40 2.93 -0.63 0.10 4.84 -5.58 2.63 5.45 -1.81 -0.02 -1.71
Income Tax Expense		 - - - - - - 0.00 - - - 0.00
Net Income / (Loss) Discontinued Operations		 - - - - - - -2.96 - - - 9.32
Weighted Average Basic Shares Outstanding		 37.98M 36.49M 43.25M 49.06M 50.03M 48.36M 51.86M 52.75M 53.49M 53.11M 54.90M
Weighted Average Diluted Shares Outstanding		 37.98M 36.49M 43.25M 49.06M 50.03M 48.36M 51.86M 52.75M 53.49M 53.11M 54.90M
Weighted Average Basic & Diluted Shares Outstanding		 39.25M 44.11M 48.78M 49.84M 50.82M 52.09M 52.50M 53.24M 54.06M 55.05M 57.61M

Annual Cash Flow Statements for Cardlytics

This table details how cash moves in and out of Cardlytics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -4.23 -1.99 39 45 189 -60 -112 -30 -26 -17
Net Cash From Operating Activities		 -32 -22 -19 11 -7.60 -39 -54 -0.19 -8.82 9.29
Net Cash From Continuing Operating Activities		 -32 -22 -19 11 -7.60 -39 -54 -0.19 -8.82 9.29
Net Income / (Loss) Continuing Operations		 -76 -20 -53 -17 -55 -129 -465 -135 -189 -103
Consolidated Net Income / (Loss)		 -76 -20 -53 -17 -55 -129 -465 -135 -189 -103
Depreciation Expense		 4.22 3.03 3.28 4.54 7.83 30 38 26 26 25
Amortization Expense		 6.36 9.08 4.23 0.10 11 20 7.79 4.70 3.82 3.69
Non-Cash Adjustments To Reconcile Net Income		 46 -0.34 30 16 33 45 506 116 167 78
Changes in Operating Assets and Liabilities, net		 -14 -14 -3.43 7.49 -3.75 -5.32 -139 -12 -16 5.82
Net Cash From Investing Activities		 -2.55 -1.65 -7.34 -11 -10 -507 -16 -10 -19 -15
Net Cash From Continuing Investing Activities		 -2.55 -1.65 -7.34 -11 -10 -507 -16 -10 -19 -15
Purchase of Property, Plant & Equipment		 -2.47 -1.59 -7.32 -11 -10 -12 -13 -12 -19 -16
Divestitures		 - - - - - 0.00 0.00 2.33 0.55 0.48
Net Cash From Financing Activities		 31 22 65 44 206 486 -40 -20 1.44 -11
Net Cash From Continuing Financing Activities		 31 22 65 44 206 486 -40 -20 1.44 -11
Repayment of Debt		 -34 -0.24 -53 -47 -0.41 -0.20 -0.21 -0.03 -205 -62
Repurchase of Common Equity		 -1.67 -2.67 -1.95 -0.20 0.00 -0.19 -40 0.00 -0.31 0.00
Issuance of Debt		 66 13 47 0.00 223 0.00 0.00 30 173 56
Issuance of Common Equity		 0.28 0.23 72 91 10 486 0.38 0.06 49 0.00
Other Financing Activities, net		 - - 0.00 0.00 -26 0.00 0.00 -50 -14 -5.00
Other Net Changes in Cash		 - - - - - - - - - 0.26
Cash Interest Paid		 - 0.87 9.73 - 0.06 2.33 2.38 4.24 6.12 9.26

Quarterly Cash Flow Statements for Cardlytics

This table details how cash moves in and out of Cardlytics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -13 1.69 5.94 -27 -4.26 -1.39 -14 -5.30 -2.78 4.76 -13
Net Cash From Operating Activities		 1.19 2.93 -18 4.43 1.39 2.98 -6.71 1.23 1.76 13 -5.64
Net Cash From Continuing Operating Activities		 -9.76 2.93 -18 4.43 1.38 2.98 -6.71 1.23 1.76 13 -5.64
Net Income / (Loss) Continuing Operations		 -24 -101 -24 -4.26 -145 -16 -13 -9.28 -73 -8.25 -4.48
Consolidated Net Income / (Loss)		 -24 -101 -24 -4.26 -145 -16 -13 -9.28 -73 -8.25 -4.48
Depreciation Expense		 5.99 6.70 6.25 6.53 6.97 5.94 6.29 6.28 6.47 6.21 4.42
Amortization Expense		 1.02 0.66 0.99 0.93 0.94 -12 1.04 1.04 0.91 0.70 0.65
Non-Cash Adjustments To Reconcile Net Income		 13 85 13 1.81 135 29 1.37 3.44 67 5.87 -6.33
Changes in Operating Assets and Liabilities, net		 -6.00 11 -14 -0.58 3.58 -4.75 -2.12 -0.24 -0.30 8.48 0.10
Net Cash From Investing Activities		 -3.15 -1.37 -4.75 -4.66 -5.26 -4.09 -3.90 -4.66 -4.46 -2.28 -2.30
Net Cash From Continuing Investing Activities		 -3.15 -1.37 -4.75 -4.66 -5.26 -4.09 -3.90 -4.66 -4.46 -2.28 -2.30
Purchase of Property, Plant & Equipment		 -3.15 -3.70 -4.75 -4.86 -5.26 -4.44 -4.10 -4.66 -4.46 -2.56 -2.30
Divestitures		 - - 0.00 0.20 - - 0.20 - - 0.28 0.00
Net Cash From Financing Activities		 0.02 0.05 28 -26 -0.39 -0.20 -3.03 -2.06 -0.01 -6.02 -5.02
Net Cash From Continuing Financing Activities		 0.02 0.05 28 -26 -0.39 -0.20 -3.03 -2.06 -0.01 -6.02 -5.02
Repayment of Debt		 -0.01 -0.01 -0.24 -205 -0.27 -0.21 -0.03 -0.06 -50 -12 -10
Issuance of Debt		 - - - - - - 0.00 - 50 6.00 5.00
Other Financing Activities, net		 - - -20 6.02 -0.00 - -3.00 -2.00 - - 0.00
Effect of Exchange Rate Changes		 - 0.08 -0.02 -0.00 - -0.09 0.10 0.19 -0.07 - -0.08
Cash Interest Paid		 1.03 1.28 1.86 0.34 0.25 3.67 0.25 3.69 0.84 4.48 0.63

Annual Balance Sheets for Cardlytics

This table presents Cardlytics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 101 154 224 423 1,264 691 574 393 286
Total Current Assets		 75 124 196 386 359 250 224 178 137
Cash & Equivalents		 21 40 104 293 233 122 92 66 49
Short-Term Investments		 - - - - - - - - 0.00
Accounts Receivable		 51 61 85 87 117 120 126 107 85
Prepaid Expenses		 2.12 3.96 5.78 5.69 7.98 7.98 6.10 5.34 3.21
Other Current Nonoperating Assets		 - - - - - - - - 0.42
Plant, Property, & Equipment, net		 7.32 10 14 14 11 5.92 3.32 2.60 1.93
Total Noncurrent Assets		 19 19 14 23 894 435 347 212 146
Goodwill		 - - - 0.00 743 353 277 159 110
Intangible Assets		 0.96 2.00 4.20 6.75 139 73 60 45 19
Other Noncurrent Operating Assets		 18 17 10 16 13 9.16 10 7.99 5.96
Other Noncurrent Nonoperating Assets		 - - - - - - - - 11
Total Liabilities & Shareholders' Equity		 101 154 224 423 1,264 691 574 393 286
Total Liabilities		 113 102 81 265 573 480 439 323 292
Total Current Liabilities		 42 52 78 81 327 249 171 149 78
Accounts Payable		 1.55 2.10 1.23 1.36 4.62 3.77 4.43 3.69 2.66
Accrued Expenses		 4.62 4.39 6.02 5.52 20 21 9.59 7.18 7.13
Current Deferred Revenue		 0.13 0.35 1.13 0.35 3.28 1.75 2.41 2.15 2.54
Current Employee Benefit Liabilities		 4.64 5.94 8.19 7.58 12 10 12 5.49 6.04
Other Current Liabilities		 31 39 62 66 288 212 143 85 58
Other Current Nonoperating Liabilities		 - - - - - - - - 1.66
Total Noncurrent Liabilities		 71 50 2.65 184 246 231 268 174 214
Long-Term Debt		 57 47 0.01 174 184 226 258 168 209
Other Noncurrent Operating Liabilities		 10 - 0.00 10 61 4.31 11 6.03 4.75
Other Noncurrent Nonoperating Liabilities		 - - - - - - - - 0.09
Total Equity & Noncontrolling Interests		 -209 52 143 157 691 212 135 70 -6.51
Total Preferred & Common Equity		 -209 52 143 157 691 212 135 70 -6.51
Total Common Equity		 -209 52 143 157 691 212 135 70 -6.51
Common Stock		 59 371 481 551 1,213 1,183 1,244 1,367 1,400
Retained Earnings		 -268 -321 -339 -394 -523 -977 -1,111 -1,301 -1,404
Accumulated Other Comprehensive Income / (Loss)		 1.07 1.99 1.31 -0.19 0.49 5.60 2.47 3.60 -2.00

Quarterly Balance Sheets for Cardlytics

This table presents Cardlytics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 635 569 534 399 369 361 293 264
Total Current Assets		 206 218 185 183 157 150 141 129
Cash & Equivalents		 90 98 71 67 52 47 44 36
Short-Term Investments		 - - - - - - - 24
Accounts Receivable		 108 111 107 110 99 97 91 66
Prepaid Expenses		 7.26 9.49 6.72 6.79 5.33 7.04 5.35 2.97
Other Current Nonoperating Assets		 - - - - - - - 0.00
Plant, Property, & Equipment, net		 3.01 2.91 3.08 2.85 2.47 2.39 2.21 1.74
Total Noncurrent Assets		 426 348 346 213 210 208 150 134
Goodwill		 353 277 277 159 159 159 110 110
Intangible Assets		 67 59 59 45 44 43 33 18
Other Noncurrent Operating Assets		 6.76 11 9.75 9.10 6.57 6.04 6.98 5.56
Other Noncurrent Nonoperating Assets		 - - - - - - - 0.00
Total Liabilities & Shareholders' Equity		 635 569 534 399 369 361 293 264
Total Liabilities		 410 370 324 330 305 302 298 268
Total Current Liabilities		 179 103 105 156 132 129 124 59
Accounts Payable		 3.48 3.97 4.87 3.93 4.45 1.95 3.61 2.60
Accrued Expenses		 9.67 4.32 6.77 8.36 8.38 6.46 7.47 9.92
Current Deferred Revenue		 3.32 1.99 1.68 2.06 2.61 3.10 3.37 2.74
Current Employee Benefit Liabilities		 11 8.09 5.49 8.25 6.44 7.24 7.30 4.57
Other Current Liabilities		 122 82 84 85 64 64 56 40
Other Current Nonoperating Liabilities		 - - - - - - - 0.00
Total Noncurrent Liabilities		 230 266 220 174 173 173 174 209
Long-Term Debt		 227 258 213 167 168 168 169 204
Other Noncurrent Operating Liabilities		 2.88 - 0.02 0.02 5.12 4.92 5.18 4.36
Other Noncurrent Nonoperating Liabilities		 - - - - - - - 0.00
Total Equity & Noncontrolling Interests		 225 199 210 70 64 59 -4.70 -4.00
Total Preferred & Common Equity		 225 199 210 70 64 59 -4.70 -4.00
Total Common Equity		 225 199 210 70 64 59 -4.70 -4.00
Common Stock		 1,230 1,332 1,347 1,356 1,377 1,385 1,393 1,405
Retained Earnings		 -1,010 -1,136 -1,140 -1,285 -1,314 -1,323 -1,396 -1,409
Accumulated Other Comprehensive Income / (Loss)		 5.30 3.05 2.95 -1.50 1.25 -3.63 -2.04 -0.53

Annual Metrics And Ratios for Cardlytics

This table displays calculated financial ratios and metrics derived from Cardlytics' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 21,411,500.00 25,711,713.00 27,464,399.00 33,269,151.00 33,165,847.00 39,254,146.00 - 54,056,548.00
DEI Adjusted Shares Outstanding		 0.00 0.00 21,411,500.00 25,711,713.00 27,464,399.00 33,269,151.00 33,165,847.00 39,254,146.00 - 54,056,548.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -2.48 -0.67 -2.02 -3.86 -14.03 -3.43 - -1.91
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 15.55% 15.59% 39.65% -11.19% 42.93% 11.76% 3.57% -10.00% -16.18%
EBITDA Growth		 0.00% 101.19% -6,129.96% 71.69% -179.01% -121.49% -466.38% 75.84% -78.13% 60.16%
EBIT Growth		 0.00% 83.60% -336.57% 66.66% -215.58% -136.50% -274.72% 71.48% -48.65% 51.43%
NOPAT Growth		 0.00% 69.59% -139.29% 57.66% -211.24% -127.36% -273.39% 70.36% -44.10% 47.92%
Net Income Growth		 0.00% 74.05% -170.06% 67.68% -223.27% -131.97% -261.89% 71.05% -40.54% 45.33%
EPS Growth		 0.00% 75.80% 64.50% 74.19% 0.00% 0.00% 0.00% 73.49% -5.96% 50.13%
Operating Cash Flow Growth		 0.00% 31.99% 14.06% 160.32% -166.32% -407.02% -39.93% 99.66% -4,669.73% 205.28%
Free Cash Flow Firm Growth		 0.00% 0.00% -23.93% 72.64% -206.71% -1,769.42% 100.79% -1,570.65% 31.85% 105.25%
Invested Capital Growth		 0.00% 0.00% 65.18% -0.26% -2.23% 1,594.76% -50.80% -4.81% -27.45% -34.01%
Revenue Q/Q Growth		 0.00% 0.00% 6.02% 11.36% -1.17% 9.41% -2.47% 2.20% -5.17% -7.13%
EBITDA Q/Q Growth		 0.00% 0.00% -33.34% 50.68% 11.16% -7.04% -767.80% 73.19% 28.72% 23.80%
EBIT Q/Q Growth		 0.00% 0.00% -22.23% 46.48% -15.05% -11.44% -352.93% 67.75% 30.44% 7.53%
NOPAT Q/Q Growth		 0.00% 0.00% -26.66% 41.05% -15.84% -9.16% -400.02% 67.34% 32.61% 2.13%
Net Income Q/Q Growth		 0.00% 0.00% -16.49% 46.65% -22.57% -4.10% -370.82% 67.32% 31.05% 6.62%
EPS Q/Q Growth		 0.00% 0.00% -105.15% 35.14% 0.00% 0.00% 0.00% 0.00% 0.00% 9.72%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 4.22% 330.39% 16.63% -19.07% -30.34% 98.86% 0.51% 1,353.71%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 46.01% -5.96% -1.79% 105.49% -414.57% -53.71% 120.16%
Invested Capital Q/Q Growth		 0.00% 0.00% 28.41% 21.24% 10.82% 1.36% -52.72% -23.41% -2.96% -13.32%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -52.25% 0.54% -28.05% -5.69% -17.86% -27.68% -140.29% -32.73% -64.78% -28.57%
Operating Margin		 -49.84% -13.12% -27.15% -8.23% -28.85% -45.90% -153.34% -43.88% -70.25% -43.65%
EBIT Margin		 -61.63% -8.75% -33.03% -7.89% -28.02% -46.37% -155.47% -42.81% -70.70% -40.97%
Profit (Net Income) Margin		 -67.09% -15.07% -35.20% -8.15% -29.65% -48.13% -155.85% -43.56% -68.02% -44.36%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 94.24% 99.69% 100.00% 100.00% 100.00%
Interest Burden Percent		 108.87% 172.26% 106.56% 103.30% 105.82% 110.14% 100.55% 101.76% 96.21% 108.29%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -101.86% -91.92% -31.28% -98.59% -25.26% -66.95% -30.83% -52.79% -39.39%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -144.78% -307.91% -22.76% -82.80% 25.47% -594.55% -60.29% -86.24% -60.99%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 422.56% -175.12% 13.72% 61.70% -5.06% -36.17% -46.94% -132.08% -286.63%
Return on Equity (ROE)		 0.00% 320.70% -267.04% -17.56% -36.89% -30.33% -103.13% -77.77% -184.88% -326.02%
Cash Return on Invested Capital (CROIC)		 0.00% -301.86% -141.08% -31.02% -96.34% -202.98% 1.13% -25.89% -20.97% 1.58%
Operating Return on Assets (OROA)		 0.00% -11.32% -39.12% -8.78% -16.19% -14.69% -47.48% -20.92% -40.70% -28.18%
Return on Assets (ROA)		 0.00% -19.49% -41.68% -9.07% -17.14% -15.25% -47.60% -21.29% -39.16% -30.51%
Return on Common Equity (ROCE)		 0.00% 5,463.68% 1,053.42% -17.56% -36.89% -30.33% -103.13% -77.77% -184.88% -326.02%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.41% -102.05% -11.97% -35.26% -18.61% -219.87% 0.00% -270.46% 0.00%
Net Operating Profit after Tax (NOPAT)		 -39 -12 -29 -12 -38 -86 -320 -95 -137 -71
NOPAT Margin		 -34.89% -9.18% -19.01% -5.76% -20.20% -32.13% -107.34% -30.71% -49.17% -30.55%
Net Nonoperating Expense Percent (NNEP)		 0.00% 42.92% 215.99% -8.52% -15.79% -50.74% 527.59% 29.46% 33.45% 21.60%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - -73.22% -24.21% -48.26% -35.21%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 18.93% 15.42% 22.72% 17.45% 24.90% 24.79% 27.28% 19.02% 20.30% 20.26%
R&D to Revenue		 12.32% 9.32% 10.76% 5.56% 9.38% 14.27% 18.23% 16.61% 17.83% 17.05%
Operating Expenses to Revenue		 149.84% 113.12% 127.15% 108.23% 128.85% 145.90% 253.34% 143.88% 170.25% 143.65%
Earnings before Interest and Taxes (EBIT)		 -70 -11 -50 -17 -52 -124 -464 -132 -197 -96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -59 0.70 -42 -12 -33 -74 -419 -101 -180 -67
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 4.46 11.28 24.94 3.18 0.91 2.68 2.69 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 4.64 11.62 26.06 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.62 0.54 1.54 7.68 20.98 8.23 0.64 1.17 0.68 0.27
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 12.87 6.16 39.04 100.43 3.35 0.94 1.75 1.54 1.55
Enterprise Value to Revenue (EV/Rev)		 0.00 2.32 1.59 7.18 20.34 8.05 0.99 1.71 1.21 0.95
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 431.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 131.94 0.00 0.00 0.00 0.00 0.00 23.94
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 54.52 0.00 0.00 77.84
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 -4.65 0.90 0.00 1.11 0.27 1.07 1.91 3.05 -32.10
Long-Term Debt to Equity		 0.00 -4.65 0.90 0.00 1.11 0.27 1.07 1.91 2.40 -32.10
Financial Leverage		 0.00 -2.92 0.57 -0.60 -0.75 -0.20 0.06 0.78 1.53 4.70
Leverage Ratio		 0.00 -8.23 6.41 1.94 2.15 1.99 2.17 3.65 4.72 10.69
Compound Leverage Factor		 0.00 -14.17 6.83 2.00 2.28 2.19 2.18 3.72 4.54 11.57
Debt to Total Capital		 0.00% 127.36% 47.33% 0.03% 52.54% 21.07% 51.65% 65.64% 75.32% 103.22%
Short-Term Debt to Total Capital		 0.00% 0.10% 0.02% 0.02% 0.00% 0.00% 0.00% 0.00% 16.17% 0.00%
Long-Term Debt to Total Capital		 0.00% 127.27% 47.31% 0.01% 52.54% 21.07% 51.65% 65.64% 59.15% 103.22%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 438.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -466.20% 52.67% 99.97% 47.46% 78.93% 48.35% 34.36% 24.68% -3.22%
Debt to EBITDA		 0.00 81.33 -1.11 0.00 -5.21 -2.49 -0.54 -2.54 -1.18 -3.14
Net Debt to EBITDA		 0.00 51.00 -0.17 8.74 3.57 0.66 -0.25 -1.64 -0.82 -2.40
Long-Term Debt to EBITDA		 0.00 81.27 -1.10 0.00 -5.21 -2.49 -0.54 -2.54 -0.93 -3.14
Debt to NOPAT		 0.00 -4.76 -1.63 0.00 -4.61 -2.15 -0.71 -2.71 -1.56 -2.93
Net Debt to NOPAT		 0.00 -2.99 -0.25 8.62 3.16 0.57 -0.32 -1.74 -1.08 -2.25
Long-Term Debt to NOPAT		 0.00 -4.76 -1.63 0.00 -4.61 -2.15 -0.71 -2.71 -1.23 -2.93
Altman Z-Score		 0.00 -2.05 -1.08 11.17 8.46 1.64 -3.52 -2.33 -5.14 -6.79
Noncontrolling Interest Sharing Ratio		 0.00% -1,603.70% 494.48% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 1.77 2.40 2.50 4.74 1.10 1.00 1.31 1.19 1.75
Quick Ratio		 0.00 1.72 1.93 2.42 4.67 1.07 0.97 1.27 1.16 1.70
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -35 -44 -12 -37 -690 5.42 -80 -54 2.86
Operating Cash Flow to CapEx		 -1,314.11% -1,392.69% -259.53% 104.26% -75.67% -309.89% -404.96% -1.49% -45.72% 58.86%
Free Cash Flow to Firm to Interest Expense		 0.00 -4.31 -13.47 -21.94 -12.10 -54.88 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -5.27 -2.68 -5.82 20.91 -2.49 -3.07 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -5.67 -2.88 -8.06 0.85 -5.79 -4.06 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 1.29 1.18 1.11 0.58 0.32 0.31 0.49 0.58 0.69
Accounts Receivable Turnover		 0.00 2.54 2.70 2.88 2.17 2.62 2.52 2.51 2.39 2.43
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 17.81 17.17 17.16 13.28 21.25 34.74 66.93 94.04 103.06
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 143.48 135.39 126.54 167.88 139.20 145.04 145.24 152.83 150.20
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 143.48 135.39 126.54 167.88 139.20 145.04 145.24 152.83 150.20
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 24 39 39 38 642 316 300 218 144
Invested Capital Turnover		 0.00 11.09 4.84 5.43 4.88 0.79 0.62 1.00 1.07 1.29
Increase / (Decrease) in Invested Capital		 0.00 24 15 -0.10 -0.86 604 -326 -15 -82 -74
Enterprise Value (EV)		 0.00 302 239 1,512 3,802 2,150 296 527 337 222
Market Capitalization		 70 70 232 1,616 3,921 2,199 192 362 189 62
Book Value per Share		 $0.00 ($64.61) $2.43 $5.57 $5.72 $20.76 $6.38 $3.43 $1.38 ($0.12)
Tangible Book Value per Share		 $0.00 ($64.91) $2.33 $5.41 $5.48 ($5.73) ($6.47) ($5.15) ($2.64) ($2.51)
Total Capital		 0.00 45 99 143 331 875 438 392 284 202
Total Debt		 0.00 57 47 0.04 174 184 226 258 214 209
Total Long-Term Debt		 0.00 57 47 0.01 174 184 226 258 168 209
Net Debt		 0.00 36 7.09 -105 -119 -49 104 166 148 160
Capital Expenditures (CapEx)		 2.47 1.59 7.32 11 10 12 13 12 19 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 11 33 13 11 -202 -121 -39 9.30 10
Debt-free Net Working Capital (DFNWC)		 0.00 33 72 117 304 31 1.10 53 75 59
Net Working Capital (NWC)		 0.00 32 72 117 304 31 1.10 53 29 59
Net Nonoperating Expense (NNE)		 36 7.67 24 5.02 18 43 145 40 52 32
Net Nonoperating Obligations (NNO)		 0.00 36 -13 -105 -119 -49 104 166 148 150
Total Depreciation and Amortization (D&A)		 11 12 7.51 4.63 19 50 45 31 16 29
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 8.65% 21.80% 6.07% 5.87% -75.69% -40.49% -12.63% 3.34% 4.36%
Debt-free Net Working Capital to Revenue		 0.00% 24.96% 48.09% 55.77% 162.83% 11.75% 0.37% 17.07% 26.91% 25.24%
Net Working Capital to Revenue		 0.00% 24.92% 48.08% 55.76% 162.83% 11.75% 0.37% 17.07% 10.43% 25.24%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($32.48) ($7.86) ($2.79) ($0.72) ($2.04) $0.00 ($13.92) ($3.69) ($3.91) ($1.95)
Adjusted Weighted Average Basic Shares Outstanding		 2.36M 3.23M 22.50M 26.70M 27.90M 0.00 33.42M 36.49M 48.36M 53.11M
Adjusted Diluted Earnings per Share		 ($32.48) ($7.86) ($2.79) ($0.72) ($2.04) $0.00 $0.00 $0.00 ($3.91) ($1.95)
Adjusted Weighted Average Diluted Shares Outstanding		 2.36M 3.23M 22.50M 26.70M 27.90M 0.00 33.61M 44.11M 48.36M 53.11M
Adjusted Basic & Diluted Earnings per Share		 ($32.48) ($7.86) ($2.79) ($0.72) ($2.04) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 2.36M 3.23M 19.06M 23.75M 27.21M 0.00 33.61M 44.11M 52.09M 55.05M
Normalized Net Operating Profit after Tax (NOPAT)		 -39 -12 -29 -12 -38 -86 -3.14 -46 -45 -30
Normalized NOPAT Margin		 -34.89% -9.18% -19.01% -5.76% -20.20% -32.13% -1.05% -14.75% -16.07% -12.90%
Pre Tax Income Margin		 -67.09% -15.07% -35.20% -8.15% -29.65% -51.07% -156.33% -43.56% -68.02% -44.36%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -11.27 -1.38 -15.25 -30.28 -17.18 -9.86 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -6.38 -1.45 -8.78 -22.13 -12.38 -6.83 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -11.67 -1.58 -17.49 -50.34 -20.48 -10.85 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -6.78 -1.65 -11.02 -42.18 -15.68 -7.82 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -2.21% -13.58% -3.67% -1.14% 0.00% -0.15% -8.63% 0.00% -0.16% 0.00%

Quarterly Metrics And Ratios for Cardlytics

This table displays calculated financial ratios and metrics derived from Cardlytics' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 37,724,209.00 39,254,146.00 44,109,102.00 48,783,041.00 49,840,104.00 - 52,085,224.00 52,502,390.00 53,236,901.00 54,056,548.00 55,054,268.00
DEI Adjusted Shares Outstanding		 37,724,209.00 39,254,146.00 44,109,102.00 48,783,041.00 49,840,104.00 - 52,085,224.00 52,502,390.00 53,236,901.00 54,056,548.00 55,054,268.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.64 -2.57 -0.55 -0.09 -2.91 - -0.26 -0.18 -1.37 -0.15 -0.08
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.66% 8.08% 5.09% -9.21% -15.12% -17.01% -16.53% -9.17% -22.41% -24.19% -39.19%
EBITDA Growth		 -184.41% 74.89% -174.25% 42.47% -746.38% 78.39% 92.84% 99.71% 53.39% 111.40% -323.28%
EBIT Growth		 -436.66% 73.55% -272.27% 31.49% -523.41% 86.10% 63.81% 53.29% 50.83% 56.02% -17.58%
NOPAT Growth		 -225.49% 73.10% -230.68% 34.99% -619.28% 91.92% 51.31% 19.12% 53.65% 26.71% 25.56%
Net Income Growth		 -482.42% 73.34% -278.39% 81.89% -505.78% 84.54% 45.29% -118.06% 49.94% 47.08% 66.27%
EPS Growth		 0.00% 0.00% -240.00% 86.57% -360.32% 87.10% 0.00% -100.00% 53.10% 58.33% 0.00%
Operating Cash Flow Growth		 108.27% 122.40% -75.05% -22.99% 16.00% 1.53% 61.93% -72.34% 27.15% 336.72% 15.87%
Free Cash Flow Firm Growth		 1,225.58% -197.98% -109.51% -86.52% -75.57% 234.85% 468.09% 334.14% -83.59% -8.87% -41.70%
Invested Capital Growth		 -41.23% -4.81% 6.07% -9.98% -42.75% -27.45% -39.03% -37.28% -26.11% -34.01% -37.88%
Revenue Q/Q Growth		 3.00% 12.86% -24.18% 3.00% -3.70% 10.35% -23.73% 2.18% -17.74% 7.81% -38.82%
EBITDA Q/Q Growth		 -11.79% -477.41% 82.50% 49.07% -1,544.78% 85.26% 83.42% 99.42% -263,600.00% 101.26% -715.29%
EBIT Q/Q Growth		 -0.51% -333.81% 76.54% 33.01% -814.55% 90.33% 38.92% 35.91% -862.75% 91.35% -63.31%
NOPAT Q/Q Growth		 15.09% -398.36% 77.82% 30.73% -839.45% 94.40% -33.67% 9.16% -438.38% 91.15% -35.77%
Net Income Q/Q Growth		 -1.95% -320.75% 75.93% 82.46% -3,310.43% 89.26% 14.80% 30.11% -682.86% 88.65% 45.70%
EPS Q/Q Growth		 5.97% -342.86% 79.93% 83.93% -3,122.22% 87.59% 0.00% 30.77% -655.56% 88.97% 0.00%
Operating Cash Flow Q/Q Growth		 -79.24% 145.73% -700.44% 125.14% -68.73% 115.09% -325.11% 118.27% 43.76% 638.78% -143.37%
Free Cash Flow Firm Q/Q Growth		 21.54% -121.80% 34.58% 177.76% 120.36% 20.31% 78.57% -6.88% -91.67% 568.08% 14.23%
Invested Capital Q/Q Growth		 -2.10% -23.41% 23.36% -2.67% -37.73% -2.96% 3.67% 0.12% -26.64% -13.32% -2.41%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -20.31% -103.89% -23.98% -11.86% -202.50% -27.05% -2.06% -0.04% -121.64% 1.42% -14.31%
Operating Margin		 -26.14% -115.43% -33.76% -22.71% -221.52% -11.24% -19.70% -20.22% -132.33% -10.86% -24.11%
EBIT Margin		 -29.18% -112.15% -34.69% -22.56% -214.30% -18.78% -15.04% -11.60% -135.82% -10.89% -29.08%
Profit (Net Income) Margin		 -30.33% -113.09% -35.91% -6.11% -216.51% -21.07% -23.54% -14.68% -139.67% -14.71% -13.05%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 128.73% 100.00% 100.00% 100.00% 32.47%
Interest Burden Percent		 103.97% 100.84% 103.49% 27.09% 101.03% 112.19% 121.56% 126.47% 102.84% 135.00% 138.26%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -10.45% -81.10% -20.51% -12.75% -147.52% -8.44% -12.34% -12.84% -119.13% -9.80% -19.45%
ROIC Less NNEP Spread (ROIC-NNEP)		 -17.93% -102.44% -26.26% -8.43% -173.11% -14.67% -15.64% -13.05% -134.17% -12.48% -18.60%
Return on Net Nonoperating Assets (RNNOA)		 -5.65% -79.77% -17.57% -5.96% -188.90% -22.48% -19.82% -15.45% -672.17% -58.63% -94.79%
Return on Equity (ROE)		 -16.10% -160.87% -38.08% -18.71% -336.42% -30.92% -32.16% -28.29% -791.30% -68.44% -114.25%
Cash Return on Invested Capital (CROIC)		 -2.93% -25.89% -39.08% -19.32% -11.47% -20.97% 5.37% 2.01% -7.26% 1.58% 8.90%
Operating Return on Assets (OROA)		 -10.38% -54.81% -17.30% -11.80% -121.61% -10.81% -8.57% -6.90% -98.57% -7.49% -19.40%
Return on Assets (ROA)		 -10.79% -55.27% -17.90% -3.20% -122.86% -12.13% -13.40% -8.73% -101.36% -10.12% -8.71%
Return on Common Equity (ROCE)		 -16.10% -160.87% -38.08% -18.71% -336.42% -30.92% -32.16% -28.29% -791.30% -68.44% -114.25%
Return on Equity Simple (ROE_SIMPLE)		 -182.90% 0.00% -86.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -14 -72 -16 -11 -104 -5.82 -7.78 -8.95 -48 -4.27 -5.79
NOPAT Margin		 -18.30% -80.80% -23.63% -15.89% -155.07% -7.87% -13.79% -14.15% -92.63% -7.60% -16.88%
Net Nonoperating Expense Percent (NNEP)		 7.49% 21.35% 5.75% -4.32% 25.60% 6.23% 3.30% 0.21% 15.03% 2.67% -0.86%
Return On Investment Capital (ROIC_SIMPLE)		 - -18.36% -3.42% -2.56% -35.66% -2.05% -2.80% -3.28% -22.96% -2.11% -2.89%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 19.70% 15.59% 21.43% 23.19% 18.01% 18.61% 22.93% 20.40% 20.86% 17.35% 24.13%
R&D to Revenue		 15.73% 14.03% 19.30% 19.34% 19.68% 13.37% 18.21% 17.86% 16.91% 14.20% 18.74%
Operating Expenses to Revenue		 126.14% 215.43% 133.76% 122.71% 321.52% 111.24% 119.70% 120.22% 232.33% 110.86% 124.11%
Earnings before Interest and Taxes (EBIT)		 -23 -100 -23 -16 -144 -14 -8.49 -7.34 -71 -6.11 -9.98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -16 -93 -16 -8.26 -136 -20 -1.16 -0.02 -63 0.80 -4.91
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.76 2.68 3.21 1.91 2.29 2.69 1.48 1.47 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.06 1.17 2.05 1.31 0.54 0.68 0.35 0.32 0.52 0.27 0.27
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.01 1.75 2.18 1.53 1.40 1.54 1.14 1.12 1.81 1.55 1.44
Enterprise Value to Revenue (EV/Rev)		 2.61 1.71 2.59 1.80 1.07 1.21 0.96 0.95 1.19 0.95 0.96
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 123.00 0.00 0.00 23.94 19.53
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 16.02 43.14 0.00 77.84 12.40
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.14 1.91 1.34 1.06 3.18 3.05 3.34 3.65 -45.63 -32.10 -51.01
Long-Term Debt to Equity		 1.01 1.91 1.33 1.05 2.49 2.40 2.62 2.87 -35.84 -32.10 -51.01
Financial Leverage		 0.32 0.78 0.67 0.71 1.09 1.53 1.27 1.18 5.01 4.70 5.10
Leverage Ratio		 2.11 3.65 2.91 2.62 3.51 4.72 3.56 3.33 10.65 10.69 10.53
Compound Leverage Factor		 2.19 3.68 3.01 0.71 3.54 5.30 4.33 4.21 10.95 14.43 14.56
Debt to Total Capital		 53.30% 65.64% 57.34% 51.38% 76.10% 75.32% 76.95% 78.50% 102.24% 103.22% 102.00%
Short-Term Debt to Total Capital		 6.22% 0.00% 0.45% 0.53% 16.51% 16.17% 16.52% 16.85% 21.94% 0.00% 0.00%
Long-Term Debt to Total Capital		 47.08% 65.64% 56.89% 50.85% 59.59% 59.15% 60.43% 61.64% 80.30% 103.22% 102.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 46.70% 34.36% 42.66% 48.62% 23.90% 24.68% 23.05% 21.50% -2.24% -3.22% -2.00%
Debt to EBITDA		 -0.68 -2.54 -1.92 -1.67 -0.88 -1.18 -1.41 -1.34 -2.45 -3.14 -2.90
Net Debt to EBITDA		 -0.44 -1.64 -1.22 -1.13 -0.61 -0.82 -1.06 -1.05 -1.95 -2.40 -2.05
Long-Term Debt to EBITDA		 -0.60 -2.54 -1.91 -1.65 -0.69 -0.93 -1.10 -1.05 -1.93 -3.14 -2.90
Debt to NOPAT		 -0.88 -2.71 -2.24 -1.95 -1.09 -1.56 -1.66 -1.67 -2.95 -2.93 -2.95
Net Debt to NOPAT		 -0.57 -1.74 -1.42 -1.33 -0.76 -1.08 -1.26 -1.30 -2.34 -2.25 -2.08
Long-Term Debt to NOPAT		 -0.78 -2.71 -2.22 -1.93 -0.86 -1.23 -1.31 -1.31 -2.31 -2.93 -2.95
Altman Z-Score		 -0.91 -2.14 -1.10 -1.59 -4.58 -3.61 -4.07 -4.22 -6.28 -5.76 -6.35
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.15 1.31 2.13 1.77 1.18 1.19 1.19 1.16 1.14 1.75 2.17
Quick Ratio		 1.10 1.27 2.04 1.71 1.13 1.16 1.15 1.11 1.09 1.70 2.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 261 -57 -37 29 64 77 137 126 10 70 80
Operating Cash Flow to CapEx		 37.95% 79.36% -371.12% 91.17% 26.35% 67.16% -163.44% 26.30% 39.45% 508.80% -244.88%
Free Cash Flow to Firm to Interest Expense		 285.04 0.00 -45.41 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 1.30 0.00 -21.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -2.13 0.00 -27.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.36 0.49 0.50 0.52 0.57 0.58 0.57 0.59 0.73 0.69 0.67
Accounts Receivable Turnover		 2.88 2.51 2.98 2.92 2.70 2.39 2.54 2.61 2.50 2.43 2.56
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 59.86 66.93 81.58 94.19 100.30 94.04 99.45 97.28 99.42 103.06 100.34
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 126.70 145.24 122.56 124.95 135.41 152.83 143.78 139.85 146.01 150.20 142.78
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 126.70 145.24 122.56 124.95 135.41 152.83 143.78 139.85 146.01 150.20 142.78
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 392 300 371 361 225 218 226 226 166 144 140
Invested Capital Turnover		 0.57 1.00 0.87 0.80 0.95 1.07 0.90 0.91 1.29 1.29 1.15
Increase / (Decrease) in Invested Capital		 -275 -15 21 -40 -168 -82 -145 -134 -59 -74 -86
Enterprise Value (EV)		 789 527 809 551 314 337 257 254 300 222 202
Market Capitalization		 622 362 639 401 159 189 95 86 129 62 58
Book Value per Share		 $5.97 $3.43 $4.51 $4.31 $1.40 $1.38 $1.23 $1.12 ($0.09) ($0.12) ($0.07)
Tangible Book Value per Share		 ($5.15) ($5.15) ($3.11) ($2.59) ($2.70) ($2.64) ($2.67) ($2.74) ($2.77) ($2.51) ($2.40)
Total Capital		 482 392 467 432 292 284 278 273 210 202 200
Total Debt		 257 258 268 222 222 214 214 214 215 209 204
Total Long-Term Debt		 227 258 266 220 174 168 168 168 169 209 204
Net Debt		 167 166 170 151 155 148 162 168 171 160 144
Capital Expenditures (CapEx)		 3.15 3.70 4.75 4.86 5.26 4.44 4.10 4.66 4.46 2.56 2.30
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -34 -39 20 12 8.58 9.30 19 21 19 10 9.37
Debt-free Net Working Capital (DFNWC)		 56 53 118 83 76 75 71 67 63 59 69
Net Working Capital (NWC)		 26 53 116 81 27 29 25 21 17 59 69
Net Nonoperating Expense (NNE)		 9.51 29 8.30 -6.81 41 9.77 5.50 0.33 24 3.98 -1.31
Net Nonoperating Obligations (NNO)		 167 166 172 151 155 148 162 168 171 150 144
Total Depreciation and Amortization (D&A)		 7.01 7.36 7.24 7.46 7.91 -6.12 7.33 7.32 7.38 6.91 5.07
Debt-free, Cash-free Net Working Capital to Revenue		 -11.25% -12.63% 6.41% 3.85% 2.93% 3.34% 7.06% 7.71% 7.61% 4.36% 4.44%
Debt-free Net Working Capital to Revenue		 18.55% 17.07% 37.69% 27.18% 25.75% 26.91% 26.55% 25.27% 25.11% 25.24% 32.76%
Net Working Capital to Revenue		 8.63% 17.07% 37.03% 26.43% 9.34% 10.43% 9.35% 7.98% 6.77% 25.24% 32.76%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.63) ($2.80) ($0.56) ($0.09) ($2.90) ($0.36) ($0.26) ($0.18) ($1.36) ($0.15) $0.00
Adjusted Weighted Average Basic Shares Outstanding		 37.98M 36.49M 43.25M 49.06M 50.03M 48.36M 51.86M 52.75M 53.49M 53.11M 54.90M
Adjusted Diluted Earnings per Share		 $0.00 ($2.79) ($0.56) ($0.09) ($2.90) ($0.36) ($0.26) ($0.18) ($1.36) ($0.15) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 39.25M 36.49M 43.25M 49.06M 50.03M 48.36M 51.86M 52.75M 53.49M 53.11M 54.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 39.25M 44.11M 48.78M 49.84M 50.82M 52.09M 52.50M 53.24M 54.06M 55.05M 57.61M
Normalized Net Operating Profit after Tax (NOPAT)		 -14 -72 -16 -11 -12 -5.82 -12 -8.81 -6.78 -4.27 -5.79
Normalized NOPAT Margin		 -18.23% -80.80% -23.63% -15.73% -17.69% -7.87% -20.42% -13.93% -13.04% -7.60% -16.88%
Pre Tax Income Margin		 -30.33% -113.09% -35.91% -6.11% -216.51% -21.07% -18.28% -14.68% -139.67% -14.71% -40.21%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -25.19 0.00 -28.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -15.80 0.00 -19.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -28.63 0.00 -34.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -19.24 0.00 -25.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.05% 0.00% 0.00% -0.09% -0.09% -0.16% 0.00% -0.06% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Cardlytics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cardlytics' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cardlytics' net income appears to be on an upward trend, with a most recent value of -$103.49 million in 2025, rising from -$75.70 million in 2016. The previous period was -$189.30 million in 2024. See where experts think Cardlytics is headed by visiting Cardlytics' forecast page.

Cardlytics' total operating income in 2025 was -$101.82 million, based on the following breakdown:
  • Total Gross Profit: $233.27 million
  • Total Operating Expenses: $335.09 million

Over the last 9 years, Cardlytics' total revenue changed from $112.82 million in 2016 to $233.27 million in 2025, a change of 106.8%.

Cardlytics' total liabilities were at $292.15 million at the end of 2025, a 9.5% decrease from 2024, and a 158.5% increase since 2017.

In the past 8 years, Cardlytics' cash and equivalents has ranged from $21.26 million in 2017 to $293.24 million in 2020, and is currently $48.72 million as of their latest financial filing in 2025.

Over the last 9 years, Cardlytics' book value per share changed from 0.00 in 2016 to -0.12 in 2025, a change of -12.0%.


Related Companies

Financial statements for NASDAQ:CDLX last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel